May.23 -- Artificial intelligence may be able to improve the drug discovery and approval processes, saving the pharmaceutical industry both time and money. Yet adoption has been slow. Bloomberg Intelligence's Elizabeth Krutoholow discusses whether pharma is ready for an AI revolution at Bloomberg's Sooner Than You Think in Paris.